Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee

NCT01688934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Pain

Interventions

DRUG: V116517 50-mg tablets
DRUG: V116517 30-mg tablets
DRUG: Naproxen 500-mg capsules
DRUG: Placebo

Sponsor

Purdue Pharma LP